Adenovirus (Ad)-hTERT combined with Ad-VEGF was shown to enhance angiogenesis, vascular remodeling, and perhaps muscle regeneration in a rat CLI model [50], and the hope is that AAV-hTERT ameliorates telomere dysfunction and augments vascular regeneration in elderly PAD patients. This evidence concerns the gene VEGFA and peripheral arterial disease.